Signal2026-07-12
NIH RePORTER

Efficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial)

Part of

Gastroenterology Clinical Research Trends

Open primary sourceSee the whole picture